梅波利祖马布在慢性鼻炎与严重鼻多重症:现实生活西班牙队列研究
Paula Cruz Toro1, Mireia Golet Fors2, Albert Llansana Ríos3
1Department of Otorhinolaryngology, Hospital Universitari Germans Trias i Pujol, Spain; University of Barcelona, Barcelona, Spain; Germans Trias i Pujol Research Institute and Hospital (IGTP), Badalona, Spain.
Acta otorrinolaringologica espanola
|March 9, 2026
概括
梅波利祖马布治疗显著改善了慢性鼻炎与鼻息肉 (CRSwNP) 患者的鼻症状和息肉大小. 这种生物疗法在12个月内证明了安全性和有效性,在使用更长时间时有可能恢复嗅觉.
科学领域:
- 免疫学 免疫学 免疫学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 药理学 药理学是指药理学的学科.
背景情况:
- 带鼻息肉的慢性鼻炎 (CRSwNP) 是一种2型炎症驱动的疾病,影响生活质量.
- 严重的CRSwNP通常会出现症状复发,尽管使用了标准疗法.
- 梅波利祖马布是一种抗类蛋白-5 (IL-5) 单克隆抗体,在控制CRSwNP.中表现有前途.
研究的目的:
- 评估mepolizumab在12个月内在CRSwNP患者中的实际有效性和安全性.
- 评估梅波利祖马布对鼻腔症状,息肉大小和嗅觉功能的影响.
- 为了比较CRSwNP患者与并发性喘和没有并发性喘患者的结果.
主要方法:
- 一项前性观察性研究,涉及28名成年CRSwNP患者接受梅波利祖马布治疗 (100毫克每4周一次).
- 标准化的评估包括鼻息肉评分 (NPS),SNOT-22,VAS和Sniffin' Sticks嗅觉测试在基线,6个月和12个月.
- 监测血液中乙酸细胞数量和不良事件.
主要成果:
- 在6个月和12个月后,观察到NPS,SNOT-22和VAS症状的显著改善 (p <0.05).
- 嗅觉功能在12个月后显著改善.
- 梅波利祖马布导致血中埃索诺菲尔的急剧下降,没有报告严重的不良事件. 患有喘和AERD的患者经历了更大的好处.
结论:
- 梅波利祖马布是一种安全有效的治疗严重的CRSwNP,产生显著的临床和内镜改善.
- 观察到的嗅觉收益表明,延长的梅波利祖马布治疗可能是完全感官恢复的必要条件.
- 现实世界的数据支持mepolizumab在治疗CRSwNP,包括并发性喘中的实用性.
相关概念视频
01:19Antiasthma Drugs: Leukotriene Modifiers
2.2K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
2.2K
01:26COPD: Management Using Bronchodilators and Corticosteroids
1.2K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.2K
01:13Asthma III: Clinical Manifestations
49
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
49
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
48
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
48
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
40
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
30
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet...
30